Our previous studies also showed that IL-25 reduced body weight gain and lipid accumulation by stimulating Type-2 macrophages (M2) polarization in nonalcoholic fatty liver disease (NAFLD) [13]. Here, IL25 is linked to metabolic dysfunction-associated steatotic liver disease.